Amanote Research

Amanote Research

    RegisterSign In

Pretargeting of Astatine-211 for Therapy of Metastic Prostate Cancer

doi 10.21236/ada374830
Full Text
Open PDF
Abstract

Available in full text

Date

August 1, 1999

Authors
D. S. Wilbur
Publisher

Defense Technical Information Center


Related search

Targeted Radionuclide Therapy With Astatine-211: Oxidative Dehalogenation of Astatobenzoate Conjugates

Scientific Reports
Multidisciplinary
2017English

Targeted Alpha Therapy With Astatine-211-Labeled Anti-Psca A11 Minibody Shows Antitumor Efficacy in Prostate Cancer Xenografts and Bone Microtumors

EJNMMI Research
Nuclear MedicineRadiologyImaging
2020English

Realizing Clinical Trials With Astatine-211: The Chemistry Infrastructure

Cancer Biotherapy and Radiopharmaceuticals
Nuclear MedicineRadiologyPharmacologyCancer ResearchOncologyImagingMedicine
2020English

Dispersal Rates of Astatine-211 From Aqueous Solutions and Chloroform

Radiation Safety Management
2019English

Focal Therapy for Prostate Cancer

Nature Reviews Urology
Urology
2009English

Initiation of Salvage Therapy for Prostate Cancer

Prostate Cancer and Prostatic Diseases
Cancer ResearchOncologyUrology
2002English

Focal TURP Therapy for Prostate Cancer

Experimental Techniques in Urology & Nephrology
2019English

Development of Reagents for Application of At-211 to Targeted Radionuclide Therapy of Cancer

2011English

Solidago Virgaurea for Prostate Cancer Therapy

2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy